South Sudan vs Eritrea vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 72% | 93% |
| 2023 | 72% | 93% |
| 2022 | 72% | 93% |
| 2021 | 74% | 93% |
| 2020 | 69% | 93% |
| 2019 | 65% | 93% |
| 2018 | 61% | 93% |
| 2017 | 56% | 93% |
| 2016 | 51% | 95% |
| 2015 | 52% | 97% |
| 2014 | 54% | 90% |
| 2013 | 57% | 94% |
| 2012 | 59% | 98% |
| 2011 | 62% | 96% |
| 2010 | - | 95% |
| 2009 | - | 93% |
| 2008 | - | 91% |
| 2007 | - | 92% |
| 2006 | - | 94% |
| 2005 | - | 95% |
| 2004 | - | 96% |
| 2003 | - | 92% |
| 2002 | - | 83% |
| 2001 | - | 84% |
| 2000 | - | 76% |
| 1999 | - | 88% |
| 1998 | - | 79% |
| 1997 | - | 73% |
| 1996 | - | 66% |
| 1995 | - | 58% |
| 1994 | - | 51% |
| 1993 | - | 34% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 73% | 95% |
| 2023 | 73% | 95% |
| 2022 | 73% | 95% |
| 2021 | 69% | 95% |
| 2020 | 67% | 95% |
| 2019 | 61% | 95% |
| 2018 | 59% | 95% |
| 2017 | 52% | 95% |
| 2016 | 45% | 95% |
| 2015 | 46% | 95% |
| 2014 | 50% | 94% |
| 2013 | 53% | 94% |
| 2012 | 63% | 94% |
| 2011 | 61% | 94% |
| 2010 | - | 95% |
| 2009 | - | 95% |
| 2008 | - | 95% |
| 2007 | - | 95% |
| 2006 | - | 94% |
| 2005 | - | 96% |
| 2004 | - | 98% |
| 2003 | - | 93% |
| 2002 | - | 90% |
| 2001 | - | 86% |
| 2000 | - | 81% |
| 1999 | - | 93% |
| 1998 | - | 86% |
| 1997 | - | 75% |
| 1996 | - | 66% |
| 1995 | - | 58% |
| 1994 | - | 49% |
| 1993 | - | 32% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 73% | 95% |
| 2023 | 73% | 95% |
| 2022 | 73% | 95% |
| 2021 | 69% | 95% |
| 2020 | 67% | 95% |
| 2019 | 61% | 95% |
| 2018 | 59% | 95% |
| 2017 | 52% | 95% |
| 2016 | 45% | 95% |
| 2015 | 46% | 95% |
| 2014 | - | 94% |
| 2013 | - | 94% |
| 2012 | - | 94% |
| 2011 | - | 94% |
| 2010 | - | 95% |
| 2009 | - | 95% |
| 2008 | - | 95% |
| 2007 | - | 95% |
| 2006 | - | 94% |
| 2005 | - | 96% |
| 2004 | - | 84% |
| 2003 | - | 91% |
| 2002 | - | 86% |
| 2001 | - | - |
| 2000 | - | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
The first measles dose reaches 72% of children aged 12–23 months in South Sudan and 93% in Eritrea: 21 percentage points more in Eritrea. The third DTP dose reaches 73% in South Sudan and 95% in Eritrea, 22 points more in Eritrea. The third hepatitis B dose reaches 73% in South Sudan and 95% in Eritrea, 22 points more in Eritrea. In 2011, the first measles dose reached 62% in South Sudan and 96% in Eritrea, 34 percentage points more in Eritrea.
South Sudan vs Eritrea: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 72% (2024) | 93% (2024) |
| DTP3 | 73% (2024) | 95% (2024) |
| HepB3 | 73% (2024) | 95% (2024) |
South Sudan and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Eritrea and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of South Sudan and its six neighbors, the latest coverage of the first measles dose is highest in Uganda, at 90%, and lowest in the Central African Republic, at 41%; of Eritrea and its three neighbors, the latest coverage of the first measles dose is highest in Eritrea, at 93%, and lowest in Sudan, at 46%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1993–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.